An Open-label Study of EZYPRO® in Atrial Fibrillation Detection on ESUS Patients
Clinical trial NCT05089435 · UNKNOWN
Trial details
- NCT number
- NCT05089435
- Sponsor
- Sigknow Biomedical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-28
- Primary completion
- 2023-03-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.